New pill targets Tough-to-Treat breast cancer in early trial
Disease control
Ongoing
This is the first human study of an experimental oral drug called AC699 for people with advanced ER+/HER2- breast cancer that has progressed after standard treatments. The main goals are to find a safe dose, understand how the body processes the drug, and look for early signs tha…
Phase: PHASE1 • Sponsor: Accutar Biotechnology Inc • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC